510(k) Report

510(k) · Cleared

Recalled · Class II · 2019

Zyno Medical Administration Set

K132841510(k) SpecialCleared Jan 23, 2014135-day reviewClass II21 CFR 880.5440Recalls 6

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Zyno Medical, LLC · FPA Set, Administration, Intravascular

Cleared on Jan 23, 2014 as substantially equivalent to K120685 (Zyno Medical, LLC, 2012) after a 135-day review. Its family tree reaches back 3 generations to 1983. It has been recalled 6 times.

Decided
Jan 23, 2014
Review
135 days
Class
Class II
Product code
FPA
Recalls
6
Predicates
1

Its longest line of descent runs back 3 generations to K832284 (1983). 5 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2006: 1 other ancestor1997: 1 other ancestorK832284 · Solution Admin. Set 2C9096 W/10 PVC · Travenol Laboratories, S.A. · 1983 · recalledK981792 · Solution Administration Set · Baxter Healthcare Corp · 1998 · recalledK120685 · Zyno Medical Administration Set · Zyno Medical, LLC · 201219801985199019952000200520102015
  1. Root · 3 generations backK832284 Solution Admin. Set 2C9096 W/10 PVCTravenol Laboratories, S.A. · 1983 · Recalled
  2. 2 generations backK981792 Solution Administration SetBaxter Healthcare Corp · 1998 · Recalled
  3. 1 generation backK120685 Zyno Medical Administration SetZyno Medical, LLC · 2012
  4. This deviceK132841 Zyno Medical Administration SetZyno Medical, LLC · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K832284Solution Admin. Set 2C9096 W/10 PVCTravenol Laboratories, S.A.19832
−2K981792Solution Administration SetBaxter Healthcare Corp19985
−1K120685Zyno Medical Administration SetZyno Medical, LLC2012—
0 (this device)K132841Zyno Medical Administration SetZyno Medical, LLC2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200610
FIG. 1 — Lineage of K132841, 1983–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K120685Zyno Medical Administration Set
Summary page 3
…f 3 testing isthat the testing data demonstrated that the device is as safe, as effective, and performs as well as the legally marketed device cleared in K 120685. IV. CLINICAL STUDY H-uman clinical Studies were deemed unnecessary to evaluate the safety or effectiveness of…
Zyno Medical, LLC2012—

Also cleared against K120685: 5 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 29, 2019Class IIZ-2058-2019Process controlAdministration sets assembled with inverted pinch clamp cause the fluid from the distal end of the administration set to be pumped to the proximal end of the tubing when secondary set is used with the primary set. Thus, instead of…
May 29, 2019Class IIZ-2059-2019Process controlAdministration sets assembled with inverted pinch clamp cause the fluid from the distal end of the administration set to be pumped to the proximal end of the tubing when secondary set is used with the primary set. Thus, instead of…
Jul 29, 2016Class IIZ-2896-2016Process controlAdministration Set potential filter leaking
Jul 29, 2016Class IIZ-2893-2016Process controlAdministration Set potential filter leaking
Jul 29, 2016Class IIZ-2895-2016Process controlAdministration Set potential filter leaking
Jul 29, 2016Class IIZ-2894-2016Process controlAdministration Set potential filter leaking

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 31 years and passes through 3 companies; a new generation was cleared every 14.1 years on median.
  • 2 of the 5 ancestors have a recall of any class.
  • 5 other devices also cite its predicate K120685.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

Zyno Medical Administration Set is a device used to administer fluids from a container to a patient's vascular system through a needle

or a catheter inserted into a vein.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K132841: Zyno Medical Administration Set.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K132841

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026